Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model
Description
Vectored immunoprophylaxis was first developed as a means of establishing engineered immunity to HIV using an adenoassociated viral vector expressing a broadly neutralizing antibody. We applied this concept to establish long-term prophylaxis against
